Increase in adoption of autoimmune disease therapeutics, surge in wide availability of advanced therapeutics, and rise in number of research and development activities drive the growth in the market. However, high initial costs related to advanced therapeutics restrain the market growth. On the other hand, strong presence of pipeline drugs and opportunities in emerging economies create new pathways in the industry.

According to the report published by Allied Market Research, the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is projected to reach $153,320 million by 2025, registering a CAGR of 4.2% from 2018 to 2025. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Request Sample Report at: 

https://www.alliedmarketresearch.com/request-sample/5185

Onkar Sumant, a Manager, Healthcare at Allied Market Research, stated, Recent launch of advanced therapeutics plays a major role in the growth of the autoimmune disease therapeutics market. Furthermore, increase in prevalence of autoimmune disease and strong presence of late stage pipeline drugs are expected to boost the market growth in the coming years.

Assistant Manager, Healthcare Research at Allied Market Research

Based on drug class, the global autoimmune disease therapeutics market is segmented into anti-inflammatory, antihyperglycemics, NSAIDs, interferons, and others. Anti-inflammatory was the major revenue contributing segment in 2017, and is expected to maintain its dominance during the forecast period owing to increase in demand for anti- inflammatory drugs, launch of newer anti- inflammatory drugs with the supportive reimbursement policies for usage of advanced anti- inflammatory drugs in some countries. Moreover, expected launch of pipeline anti-inflammatories such as tocilizumab, certolizumab, secukinumab, etanercept, golimumab, and others, is estimated to further influence the market growth.

Drug stores & retail pharmacies to maintain its dominant position by 2025

Drug stores & retail pharmacies accounted for nearly three-fifths of the total share in 2017 and will maintain its dominant position by 2025, owing to ease in availability offered by them and presence of large number of stores. However, online stores would grow at the fastest rate, registering a CAGR of 6.8% from 2018 to 2025, owing to rise in preference for online channels and advantages such as less expenses, enhanced convenience, and easy access to reviews of other patients.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/5185

North America accounted for a major market share in 2017, and is expected to remain dominant throughout the forecast period. Higher prevalence of autoimmune disease, early diagnosis, easy availability of advanced therapeutics, strong presence of key players, favorable reimbursement in healthcare system, and higher number of trained medical professionals are key drivers of the North America autoimmune disease therapeutics market. On the other side, Asia-Pacific is expected to experience the highest growth rate during the forecast period owing to increase in number of target population, rise in adoption of therapeutics with development in healthcare infrastructure.

Leading market players

Leading market players analyzed in the research include Abbott Laboratories, Amgen Inc., AbbVie Inc.,

Bristol-Myers Squibb Company, AstraZeneca plc., Johnson & Johnson, F. Hoffmann-La Roche AG, Pfizer Inc., Novartis AG, and UCB S.A.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

Contact us:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

Toll Free: 1-800-792-5285 |UK: +44-845-528-1300 | Hong Kong: +852-301-84916 | India (Pune): +91-20-66346060 | Fax: +1-855-550-5975 Email” help@alliedmarketresearch.com
Follow us on LinkedIn, Facebook, Twitter, Pinterest, YouTube & Instagram

Leave a comment

Your email address will not be published.